InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Schoeneck James A, Director. Director active across 2 companies, notably FIBROGEN INC. Cumulatively, 10 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €81k. Activity tracked since 26 May 2021. The latest transaction was disclosed on 20 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
250,000 shares@ US$0.352100.0% of flowCommon StockSEC:0001415889-25-008823:0
Canonical exit: 18 Jun 2025 (T+90)
79,687 sharesCommon StockSEC:0001493152-24-026115:0
28,207 sharesCommon StockSEC:0001493152-24-026108:0
173,000 shares@ US$0.2016.7% of flowCommon StockSEC:0001493152-24-022745:0
375,000 shares@ US$0.4074.1% of flowCommon StockSEC:0001493152-24-015572:0
10,625 shares@ US$1.809.2% of flowCommon StockSEC:0001493152-24-001134:0
8,289 shares0Common StockSEC:0001209191-23-036073:0
15,777 shares0Common StockSEC:0001209191-22-038598:0
4,700 shares0Common StockSEC:0001209191-21-036684:0
4,700 shares0Common StockSEC:0001209191-21-036684
10 of 10 declarations
About Schoeneck James A
James A. Schoeneck is a Director at FibroGen Inc. He contributes to the governance of the company by participating in defining its strategy and overseeing its activities. His expertise in the biopharmaceutical field is an asset for the company.
